Clinicopathological Spectrum and Treatment Outcome of Clinically Suspected Rapidly Progressive Glomerulonephritis: An Analysis of 35 Cases in a Tertiary Care Center, Bangladesh
Journal of Pediatric Nephrology,
Vol. 7 No. 3 (2019),
Background and Aim: Rapidly progressive glomerulonephritis (RPGN) is characterized by a rapid decline in the renal function and urinary abnormalities. There is limited information on epidemiological factors and clinical and histopathological patterns of RPGN from developing countries. Therefore, the objective of this study was to identify the etiology, clinical features, histopathological patterns, and treatment outcomes of patients with clinically suspected RPGN.
Methods: This retrospective study was conducted in the Pediatric Nephrology Department of Bangabandhu Sheikh Mujib Medical University from January 2014 to January 2019. Patients with clinically suspected RPGN that underwent renal biopsy were enrolled in this study.
Results: Thirty-five patients were recruited in this study. Macroscopic hematuria, edema, hypertension, uremia, and oliguria were common clinical presentations. Diffuse proliferative GN (28.5%) and crescentic GN (22.8%) were the most common histological diagnoses in this study. Immune mediated GN (62%) followed by idiopathic GN (25%) were found to be the most frequent cause of crescentic GN. Renal replacement therapy was required in 45% of the cases and 11.4% of the patients developed end-stage renal disease.
Conclusion: Renal histology is an integral part of the investigation of patients with suspected RPGN for both diagnostic and prognostic purposes. Diffuse proliferative GN was the most common histopathological diagnosis in patients with clinical RPGN in our population. Preservation of renal function depends on early intervention and detection of RPGN in pediatric patients.
Keywords: Nephritis; Glomerulonephritis; ESRD; End-Stage Kidney Disease; Child.
- Rapidly progressive glomerulonephritis
- crescentic glomerulonephritis
- diffuse proliferative GN
- end stage renal disease
How to Cite
Cho HY, Chung DL, Kang JH, Ha IS, Cheong HI, Choi Y. A Clinico-pathological study of rapidly progressive glomerulonephritis in children. Journal of the Korean Society of Pediatric Nephrology 2004; 8(2):176-85.
George HB, Greenhall, Alan D, Salam. What is new in the management of rapidly progressive glomerulonephritis? Clin Kidney J 2015; 8(2):143-50.
Moroni G, Ponticelli C. Rapidly progressive crescentic glomerulonephritis: Early treatment is a must. Autoimmun Rev 2014; 13(7):723-29.
Hedger N, Stevens J, Drey N, Walker S, Roderick P. Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: A10- year retrospective study. Nephrol. Dial. Transpl. 2000;15:1593-9.
Lee T, Gasim A, Derbail VK, Chung Y, Mcgregor JAG, Lionaki S, Poulton CJ, Hogan SL, Jennette JC, Falk RJ et al. Predictors of treatment outcomes in ANCA- associated vasculitis with severe kidney failure. Clin. J. Am. Soc. Nephrol 2014,9:905-13.
Habib MA, Badruddoza SM. Pattern of glomerular disease among adults in Rajshahi, the Northern Region of Bangladesh. Saudi J Kidney Dis Transpl 2012;23:876-80.
David S, Baldwin DS, Neugarten J, Gluck M, Spinowit B, Feiner HD. The existence of a protracted course in crescentic glomerulonephritis. Kidney Int 1987;31:790.
Rowaiye OO, Kusztal M, Klinger M. The Kidneys and ANCA-associated vasculitis: From pathogenesis to diagnosis. Clin. Kidney. J 2015;8:343-50.
Zent R, Van Zyl, Smith R, Duffield M, Cassidy MJ. Crescentic Glomerulonephritis at Goote Shuur Hospital, South Africa, not a benign disease. Clin Nephrol 1994;22-9.
Nikolic-Paterson DJ, Atkins RC. The role of macrophages in glomerulonephritis. Nephrol Dial Transplant 2001;16:3-7.
Singh SK, Jeansson M, Quaggin SE. New insights into pathogenesis of cellular crescents. Curr. Opin. Nephrol. Hypertens 2011; 20:258-62.
Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC Joh K et al. Histopathologic Classification of ANCA-Associated Glomerulonephritis. J Am Soc Nephrol 2010;21:1628-36.
Kambham N. Crescentic glomerulonephritis: an update on pauci-immune and anti-GBM disease. Advances in Anatomic Pathology 2012;2(19);111-24.
Couser WG. Rapidly progressive glomerulonephritis: Classification, pathogenetic mechanism, and therapy. Am. J. Kidney Dis 1988; 11:449-64.
Jennette JC, Thomas DB. Crescentic glomerulonephritis. Nephrol. Dial. Transpl. 2001;16:80-2.
Langford CA. Complications of cyclophosphamide therapy.Eur. Arch. Otorhinolaryngol 1997; 254:65-72.
Kaldas A, Warraich I, Prabhakar SS. ANCA Associated Glomerulonephritis-An In-Depth Review. J. Nephrol .Ther 2003; 4: 1.
Pepper RJ, Chanouuzas D, Tarzi R, Little MA, Casian A, Walsh M, Pusey CD, Harper L, Salama AD. Intravenous cyclophpsohamide and plasmapheresis in dialysis- dependant ANCA- associated vasculitis. Clin. J. Am. Soc. Nephrol 2013;8: 219-4.
Niaudet P, Boyer O. 2016, ‘Idiopathic nephrotic syndrome in children: clinical aspects’. In: Avner ED, Harmon WE, Niaudet P. Yoshikawa N, et al, Pediatric nephrology 7th ed, Springer Berlin Heidelberg: Germany:840-69.
Tauhidul Alam Choudhury1, Rana Gopal Singh2, Usha. Clinicopathologic Spectrum of Crescentic Glomerulonephritis:A Hospital-based Study. Saudi J Kidney Dis Transpl 2014;25(3):689-96.
Srivastava RN and Bagga A. 2016, 'Chronic kidney disease' In: Srivastava RN, Bagga, A (eds.), Pediatric Nephrology, 5th ed., Jaypee Brothers Medical Publishers (P) Ltd, New Delhi;375-412.
Gupta R, Singh L, Sharma A, Bagga A,Agarwal SK, Dinda AK. Crescentic glome-rulonephritis: A clinical and histomorpho-logical analysis of 46 cases. Indian J PatholMicrobiol 2011;54:495-500.
Sinha A, Puri K, Hari P, Dinda AK, Bagga A. Etiology and outcome officer crescentic glomerulonephritis. Indian Pediatr 2013;50:283-8.
Alsaad K, Oudah N, Al Ameer A, Fakeeh K, Al Jomaih A, Al Sayyari A. Glomerulonephritis with crescents in children: etiology and predictors of renal outcome. ISRN Pediatr 2011;2011:507298.
Schwartzman-Morris J, Putterman C. Gender differences in the pathogenesis and outcome of lupus and of lupus nephritis. Clinical and Developmental Immunology. 2012 May 29;2012.
Rampelli SK, Rajesh NG, Srinivas BH, Harichandra Kumar KT, Swaminathan RP, Priyamvada PS. Clinical spectrum and outcomes of crescentic glomerulonephritis: A single center experience. Indian J Nephrol 2016;26:252-6.
Dewan D, Gulati S, Sharma RK, Prasad N, Jain M, Gupta A, et al. Clinical spectrum and outcome of crescentic glomerulonephritis in children in developing countries. Pediatr Nephrol 2008; 23:389-94.
Vanikar AV, Kanodia KV, Patel RD, Trivedi HL. Primary immunoglobulin A (IgA) nephropathy in Western India. Indian J Nephrol 2005;15:227‑31.
Lin W, Chen M, Cui Z, Zhao MH. The immunopathological spectrum of crescentic glomerulonephritis: A survey of 106 patients in a single Chinese center. Nephron Clin Pract 2010;116:c65‑74.
- Abstract Viewed: 243 times
- PDF Downloaded: 135 times